Oncology Market Access under New Payment and Delivery Models

2014 Speaking Faculty

	Steven Bloom Senior Vice President Business Development, Commercial Development, and Advocacy Relations ZIOPHARM Oncology Adjunct Faculty University of Rhode Island College of Pharmacy Member, Scientific Advisory Board Cary Pharmaceuticals

	Barry D. Brooks, MD Chairperson, Drug Contracting Committee Medical Director and Chairperson, Pharmacy & Therapeutics Executive Committee US Oncology Network Partner, Texas Oncology Clinical Associate Professor, University of Texas Health Science Center

	Don Creighton Senior Director, ICON Commercialisation and Outcomes Editorial Advisory Board, *Pharmaceutical Executive*

	Jeffrey Davis, JD Associate Counsel Safety Net Hospitals for Pharmaceutical Access

	Thomas W. Feeley, MD Head, Institute for Cancer Care Innovation Head, Division of Anesthesiology and Critical Care Helen Shafer Fly Distinguished Professor of Anesthesiology University of Texas M.D. Anderson Cancer Center Member, Committee on Improving the Quality of Cancer Care Institute of Medicine Task Force Member Center for American Progress

	Robert Freeman, PhD Professor of Pharmacy Administration, Department of Pharmacy Practice and Administration University of Maryland Eastern Shore School of Pharmacy

	Jonathan Gavras, MD, FCCP Senior Vice President, Delivery System Chief Medical Officer Florida Blue

	Urte Gayko, PhD Senior Vice President, Global Regulatory Affairs Pharmacyclics

	Lindee Goh, PhD Partner Tapestry Networks

	Kjel A. Johnson, PharmD, BCPS, FCCP, FAMCP Vice President, Global Oncology IMS Health Publisher, *ManagedCare Oncology*

	Anil Kapur Vice President, Commercial Leader, Hematology Oncology Franchise Johnson & Johnson

	Michael Kolodziej, MD National Medical Director, Oncology Solutions Aetna

	Johnathan M. Lancaster, MD, PhD Gynecologic Oncologist President, Moffitt Medical Group Moffitt Cancer Center

	Kathleen G. Lokay President and Chief Executive Officer D3 Oncology Solutions Via Oncology Pathways

	Tom Martin Research Director Health Strategies Group

	William McGivney, PhD Principal, McGivney Global Advisors, LLC Former Chief Executive Officer, National Comprehensive Cancer Network Founder, NCCN Drugs/Biologics Compendium Former FDA Liaison, American Medical Association

	Sarfaraz K. Niazi, PhD Executive Chairperson and Chief Executive Officer Therapeutic Proteins International

	Vivian Park, PharmD, MBA, BCOP Clinical Coordinator, Drug Policy Management Memorial Sloan-Kettering Cancer Center

	Kavita Patel, MD, MS Fellow and Managing Director of Delivery System Reform and Clinical Transformation Engelberg Center for Health Care Reform Brookings Institution

	Lori M. Reilly, Esq Executive Vice President, Policy and Research, PhRMA Board Member, Personalized Medicine Coalition Editorial Advisory Board Member, Policy Forum, The Food and Drug Law Institute

	Richard L. Schilsky, MD, FASCO Chief Medical Officer American Society of Clinical Oncology Professor Emeritus University of Chicago

	Nishan Sengupta, PhD, RPh Global Market Access Leader, Oncology Johnson & Johnson

	Surya Singh, MD Corporate Vice President, Specialty Client Solutions, CVS Caremark Hospitalist, Brigham and Women’s Hospital Adjunct Instructor of Medicine, Harvard Medical School

	Andrew Thorrens Head, Reimbursement and Market Access Durata Therapeutics

	Susan Weber Director, Brand Access Analysis Health Strategies Group

	Burt Zweigenhaft CEO Onco360

Home :: Health Care :: Legal & IP :: Pharmaceutical :: Live Stream

Opportunities :: Compendium Products :: News :: Videos :: About :: Site Map :: Privacy

© 2015 World Congress | 500 West Cummings Park, Suite 5400 | Woburn, MA 01801 | 800-767-9499